HACOR Score may predict NIV Failure among Post-TB Obstructive Airway Disease Patients: Study
INDIA: A recent study published in the Journal of the Association of Physicians of India concluded that The HACOR score is useful for predicting the likelihood of non-invasive ventilation (NIV) failure in patients experiencing an acute exacerbation of post-tuberculosis obstructive airway disease (TB-OAD).
Post- Post-Tuberculosis obstructive airway disease is associated with pulmonary TB. In India, smoking is a common cause of chronic AOD. Cough, breathlessness, obstructive abnormality, and spirometry are the symptoms which are associated with it. Inhaled steroids and inhaled bronchodilators are the mainstay treatment of post-TB-OAD. Hypoxia and respiratory fatigue are the indicators for hospitalization. Considering this, Siddharth R Waghmare, from the Department of Respiratory Medicine, Lokmanya Tilak Municipal Medical College and General Hospital (LTMGH), Mumbai, Maharashtra, India, et.al conducted a study to assess the utility of HACOR score in acute exacerbation of post- tuberculosis obstructive airway disease ( post – TB-OAD).
For this purpose, the research team conducted an observational study with 100 patients with acute exacerbation of post-TB-OAD. HACOR score was calculated for patients in acute exacerbation of post-TB-OAD who needed non-invasive ventilation (NIV) support in 1,12,24,48 hours. A cutoff score of >5 was used, and the specificity, sensitivity, positive predictive value, and negative predicted value were calculated.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.